IBM and CLC bio Deliver Combined Turnkey Genomics Sequencing Analytics Solution

News   Apr 10, 2013

 
IBM and CLC bio Deliver Combined Turnkey Genomics Sequencing Analytics Solution
 
 
 

RELATED ARTICLES

The Resilience of the Down's Syndrome Genome

News

People with Down's Syndrome have a genome optimised against rare mutation and a well-balanced gene expression rate, a study suggests.

READ MORE

Watch: Could Digital Microfluidics Revolutionise Experimentation?

News

Technology using 'programmable droplets' could enable automated research on a grand scale.

READ MORE

New Research Could Significantly Accelerate Drug Discovery

News

Scientists have developed a suite of computer programs that cull through data on structure and genomic sequencing to identify the features that distinguish one enzyme from similar enzymes. This research has the potential to significantly accelerate drug discovery, allowing scientists to develop more effective drugs, more quickly.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE